Regulation of Mammary Stem/Progenitor Cells by PTEN/Akt/β-Catenin Signaling
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Recent evidence suggests that many malignancies, including breast cancer, are driven by a cellular subcomponent that displays stem cell-like properties. The protein phosphatase and tensin homolog (PTEN) is inactivated in a wide range of human cancers, an alteration that is associated with a poor prognosis. Because PTEN has been reported to play a role in the maintenance of embryonic and tissue-specific stem cells, we investigated the role of the PTEN/Akt pathway in the regulation of normal and malignant mammary stem/progenitor cell populations. We demonstrate that activation of this pathway, via PTEN knockdown, enriches for normal and malignant human mammary stem/progenitor cells in vitro and in vivo. Knockdown of PTEN in normal human mammary epithelial cells enriches for the stem/progenitor cell compartment, generating atypical hyperplastic lesions in humanized NOD/SCID mice. Akt-driven stem/progenitor cell enrichment is mediated by activation of the Wnt/beta-catenin pathway through the phosphorylation of GSK3-beta. In contrast to chemotherapy, the Akt inhibitor perifosine is able to target the tumorigenic cell population in breast tumor xenografts. These studies demonstrate an important role for the PTEN/PI3-K/Akt/beta-catenin pathway in the regulation of normal and malignant stem/progenitor cell populations and suggest that agents that inhibit this pathway are able to effectively target tumorigenic breast cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Knockdown of PTEN in normal mammary epithelial cells implanted into humanized mouse fat pads resulted in disorganized, hyperplastic lesions (44).”
From Mislocalization of the Cell Polarity Protein Scribble Promotes Mammary Tumorigenesis and Is Associated with Basal Breast Cancer (2014) · cites this paper as [44]
In the citing paper
“These outgrowths displayed increased basal markers (smooth muscle actin, CK5, CK6) and decreased luminal markers (estrogen receptor, CK18), similar to our findings with mislocalization of SCRIB.”
From Mislocalization of the Cell Polarity Protein Scribble Promotes Mammary Tumorigenesis and Is Associated with Basal Breast Cancer (2014) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012 · cited 8×
“Mammary tissue from reduction mammoplasties was dissociated as previously described [19].”
BackgroundMethodInfluentialSelf-citationA collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J.-P., Tong, F., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,188 · cited 1×
“screened 38 breast cancer cell lines including MCF7 for various pathways and found that MCF7 cells displayed significantly low levels of the PI3/Akt activation when compared with other cell lines [52].”
BackgroundmTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561 · cited 1×
“loop [43–46].”
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,406 · cited 2×
“Mammosphere cultures were grown in a serum-free mammary epithelium basal medium as previously described [18].”
BackgroundMethodSelf-citationSato, N., Meijer, L., Skaltsounis, L., Greengard, P., & Brivanlou, A. H. (2004) · Nature Medicine · doi:10.1038/nm979 · Cited by 2,109 · cited 1×
“To examine the role of Wnt/b-catenin signaling, we used the GSK3-b inhibitor 6-bromoindirubin-39-oxime (Bio), which has been shown to be able to maintain pluripotency of human and mouse embryonic stem cells through activation of bcatenin signaling [30].”
MethodNagata, Y., Lan, K.-H., Zhou, X., Tan, M., Esteva, F. J., Sahin, A. A., Klos, K. S., Li, P., Monia, B. P., Nguyen, N. T., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.022 · Cited by 1,858 · cited 2×
“therapeutic agents and relapse following initial treatment [7,8].”
BackgroundInfluentialIntrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
Li, X., Lewis, M. T., Huang, J., Gutierrez, C., Osborne, C. K., Wu, M.-F., Hilsenbeck, S. G., Pavlick, A., Zhang, X., Chamness, G. C., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn123 · Cited by 1,794 · cited 1×
“Recent evidence utilizing in vitro systems [56], animal models [13], and clinical trials have suggested that breast cancer stem cells are relatively resistant to both radiation and chemotherapy [57].”
BackgroundBerns, K., Horlings, H. M., Hennessy, B. T., Madiredjo, M., Hijmans, E. M., Beelen, K., Linn, S. C., Gonzalez-Angulo, A. M., Stemke-Hale, K., Hauptmann, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.030 · Cited by 1,627
Purification and unique properties of mammary epithelial stem cells
Stingl, J., Eirew, P., Ricketson, I., Shackleton, M., Vaillant, F., Choi, D., Li, H. I., & Eaves, C. J. (2006) · Nature · doi:10.1038/nature04496 · Cited by 1,559 · cited 1×
“Furthermore, recent studies have shown that mammary stem cells are not contained within the SP population [47].”
BackgroundPten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,516 · cited 2×
“heterozygous mice developing tumors in several organs including the breast [5,34].”
Background
Cited by
Breast cancer: Biology, biomarkers, and treatments
Barzaman, K., Karami, J., Zarei, Z., Hosseinzadeh, A., Kazemi, M. H., Moradi-Kalbolandi, S., Safari, E., & Farahmand, L. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106535 · Cited by 973
Sever, R., & Brugge, J. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006098 · Cited by 989
“…inhibition of GSK3 by Akt may, in certain contexts, lead to stabilization and nuclear translocation of the Wnt target b-catenin (Haq et al. 2003; Korkaya et al. 2009; Ma et al. 2013), a transcriptional regulator whose degradation would otherwise be promoted by GSK3 (Polakis 2001; Korkaya et al.…”
InfluentialSustained proliferation in cancer: Mechanisms and novel therapeutic targets
Feitelson, M. A., Arzumanyan, A., Kulathinal, R. J., Blain, S. W., Holcombe, R. F., Mahajna, J., Marino, M., Martinez-Chantar, M. L., Nawroth, R., Sanchez-Garcia, I., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.006 · Cited by 778
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
Ginestier, C., Liu, S., Diebel, M. E., Korkaya, H., Luo, M., Brown, M., Wicinski, J., Cabaud, O., Charafe-Jauffret, E., Birnbaum, D., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39397 · Cited by 747
Self-citationTsai, H.-C., Li, H., Van Neste, L., Cai, Y., Robert, C., Rassool, F. V., Shin, J. J., Harbom, K. M., Beaty, R., Pappou, E., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.029 · Cited by 650
“…suspension as tumor spheres and serial passaged to test for self-renewal capacity and stem-like cell activity (Figure 4A) (McDermott andWicha, 2010; Korkaya et al., 2009; Charafe-Jauffret et al., 2009; Dontu et al., 2003; Ginestier et al., 2007; (C) gH2AX foci formation in CD34+ and CD34 Kasumi-1…”
BackgroundAntiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia
Conley, S. J., Gheordunescu, E., Kakarala, P., Newman, B., Korkaya, H., Heath, A. N., Clouthier, S. G., & Wicha, M. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018866109 · Cited by 663
“We previously demonstrated that Akt activation increases breast CSC self-renewal through stimulation of the Wnt pathway (18).”
BackgroundSelf-citationBreast cancer stem cells, cytokine networks, and the tumor microenvironment
Korkaya, H., Liu, S., & Wicha, M. S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57099 · Cited by 616
Self-citationKeeping abreast of the mammary epithelial hierarchy and breast tumorigenesis
Visvader, J. E. (2009) · Genes & Development · doi:10.1101/gad.1849509 · Cited by 571
“Inhibition of AKT activity, up-regulated upon loss of pTEN, was found to be effective in targeting ALDH1+ tumor-initiating cells (Korkaya et al. 2009).”
BackgroundCancer Chemoprevention by Carotenoids
Tanaka, T., Shnimizu, M., & Moriwaki, H. (2012) · Molecules · doi:10.3390/molecules17033202 · Cited by 589
“Furthermore, the PI3K/Akt pathway is important in regulating the mammary stem/progenitor cells by promoting β-catenin downstream events through the phosphorylation of GSK3β [247].”
BackgroundSulforaphane, a Dietary Component of Broccoli/Broccoli Sprouts, Inhibits Breast Cancer Stem Cells
Li, Y., Zhang, T., Korkaya, H., Liu, S., Lee, H.-F., Newman, B., Yu, Y., Clouthier, S. G., Schwartz, S. J., Wicha, M. S., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2937 · Cited by 559
“Although the decreased ALDH-positive cell population in sulforaphane-treated tumors suggests that sulforaphane may target breast cancer stem/progenitor cells, the ability of residual cancer cells to initiate tumors upon reimplantation in secondary mice is a more definitive assay (6).”
BackgroundSelf-citationSteelman, L. S., Chappell, W. H., Abrams, S. L., Kempf, C. R., Long, J., Laidler, P., Mijatovic, S., Maksimovic-Ivanic, D., Stivala, F., Mazzarino, M. C., et al. (2011) · Aging · doi:10.18632/aging.100296 · Cited by 553
Korkaya, H., Kim, G.-I., Davis, A., Malik, F., Henry, N. L., Ithimakin, S., Quraishi, A. A., Tawakkol, N., D'Angelo, R., Paulson, A. K., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.06.014 · Cited by 538
“We have previously reported that PTEN downregulation increases the breast CSC population via Akt activation of the Wnt signaling pathway (Korkaya et al., 2009).”
BackgroundMethodInfluentialSelf-citationChappell, W. H., Steelman, L. S., Long, J. M., Kempf, R. C., Abrams, S. L., Franklin, R. A., Bäsecke, J., Stivala, F., Donia, M., Fagone, P., et al. (2011) · Oncotarget · doi:10.18632/oncotarget.240 · Cited by 510
“An area of intense research interest in experimental therapeutics is the cancer stem cell, more appropriately referred to as the cancer initiating cell (CIC) [89, 187-243].”
BackgroundTargeting breast stem cells with the cancer preventive compounds curcumin and piperine
Kakarala, M., Brenner, D. E., Korkaya, H., Cheng, C., Tazi, K., Ginestier, C., Liu, S., Dontu, G., & Wicha, M. S. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0612-x · Cited by 503
“In addition to canonical Wnt signaling, other signal transduction pathways, including Akt, may also regulate stem cell self-renewal through downstream Wnt signaling [27].”
BackgroundSelf-citationCancer Stem Cells and Self-renewal
O'Brien, C. A., Kreso, A., & Jamieson, C. H. M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2824 · Cited by 472
“In order to prove that a particular marker enriches for CSC activity, in vivo limiting dilution assays (LDA) Clin Cancer Res; 16(12) June 15, 2010 must be done with both the tumor-initiating and nontumor-initiating fractions; additional attention must be paid to the latter in order to ensure that the injected cells ar…”
BackgroundInfluentialYAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29
Tumaneng, K., Schlegelmilch, K., Russell, R. C., Yimlamai, D., Basnet, H., Mahadevan, N., Fitamant, J., Bardeesy, N., Camargo, F. D., & Guan, K.-L. (2012) · Nature Cell Biology · doi:10.1038/ncb2615 · Cited by 453
Mechanisms of aromatase inhibitor resistance
Ma, C. X., Reinert, T., Chmielewska, I., & Ellis, M. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3920 · Cited by 407
Curcumin, a component of turmeric: From farm to pharmacy
Gupta, S. C., Kismali, G., & Aggarwal, B. B. (2013) · BioFactors · doi:10.1002/biof.1079 · Cited by 396
Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
Brooks, M. D., Burness, M. L., & Wicha, M. S. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.08.014 · Cited by 374
“In addition to direct mitogenic effects of estrogen, luminal subtype CSCs may be regulated by growth factor pathways including PI3K, mTOR, and HER2 (Ithimakin et al., 2013; Korkaya et al., 2009; Zhang et al., 2012b; Zhou et al., 2007).”
BackgroundSelf-citationGong, C., Bauvy, C., Tonelli, G., Yue, W., Deloménie, C., Nicolas, V, Zhu, Y., Domergue, V, Marin-Esteban, V, Tharinger, H., et al. (2013) · Oncogene · doi:10.1038/onc.2012.252 · Cited by 369
Inflammatory Breast Cancer: The Disease, the Biology, the Treatment
Robertson, F. M., Bondy, M., Yang, W., Yamauchi, H., Wiggins, S., Kamrudin, S., Krishnamurthy, S., Le-Petross, H., Bidaut, L., Player, A. N., et al. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20082 · Cited by 366
Targeting Breast Cancer Stem Cells
Liu, S., & Wicha, M. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.5388 · Cited by 356
Self-citationSalinomycin as a Drug for Targeting Human Cancer Stem Cells
Naujokat, C., & Steinhart, R. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/950658 · Cited by 351
“Salinomycin, a polyether ionophore antibiotic isolated from Streptomyces albus, has been shown to kill CSCs in different types of human cancers, most likely by interfering with ABC drug transporters, the Wnt/β-catenin signaling pathway, and other CSC pathways.”
BackgroundRegulation of Cancer Stem Cells by Cytokine Networks: Attacking Cancer's Inflammatory Roots
Korkaya, H., Liu, S., & Wicha, M. S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2743 · Cited by 334
Self-citationMicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis
Cai, J., Guan, H., Fang, L., Yang, Y., Zhu, X., Yuan, J., Wu, J., & Li, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65871 · Cited by 331
The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence
Auffinger, B., Spencer, D., Pytel, P., Ahmed, A. U., & Lesniak, M. S. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1051968 · Cited by 292
BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance
Gorodetska, I., Kozeretska, I., & Dubrovska, A. (2019) · Journal of Cancer · doi:10.7150/jca.30410 · Cited by 269
“Loss of BRCA functions results in the genomic instability that eventually results in the oncogenic transformation of non-tumorigenic cells into tumor initiating cells, or cancer stem cells (CSCs) and further tumor evolution.”
BackgroundInfluentialKasimir-Bauer, S., Hoffmann, O., Wallwiener, D., Kimmig, R., & Fehm, T. (2012) · Breast Cancer Research · doi:10.1186/bcr3099 · Cited by 284
“In addition, CTC from patients with primary and metastatic breast cancer were shown to express receptors and activated signaling kinases of the EGFR/HER2/PI3K/Akt pathway [16], which has been described as one of the major pathways in the regulation of mammary stem/progenitor cells, promoting proliferation and the inhi…”
BackgroundCancer stem cells: A review from origin to therapeutic implications
Atashzar, M. R., Baharlou, R., Karami, J., Abdollahi, H., Rezaei, R., Pourramezan, F., & Zoljalali Moghaddam, S. H. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29044 · Cited by 281
Epithelial–mesenchymal transition and breast cancer: Role, molecular mechanisms and clinical impact
Foroni, C., Broggini, M., Generali, D., & Damia, G. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.11.001 · Cited by 282
Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells
Song, C. W., Lee, H., Dings, R. P. M., Williams, B., Powers, J., Santos, T. D., Choi, B.-H., & Park, H. J. (2012) · Scientific Reports · doi:10.1038/srep00362 · Cited by 280
Role of Notch and its oncogenic signaling crosstalk in breast cancer
Guo, S., Liu, M., & Gonzalez-Perez, R. R. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.12.002 · Cited by 260
Mierke, C. T. (2019) · Reports on Progress in Physics · doi:10.1088/1361-6633/ab1628 · Cited by 262
Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms
Sinha, D., Sarkar, N., Biswas, J., & Bishayee, A. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.11.001 · Cited by 258
Cancer stem cell plasticity and tumor hierarchy
Cabrera, M. C. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i1.27 · Cited by 252
Davis, N. M., Sokolosky, M., Stadelman, K., Abrams, S. L., Libra, M., Candido, S., Nicoletti, F., Polesel, J., Maestro, R., D’Assoro, A., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2209 · Cited by 250
Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells
Singh, J. K., Simões, B. M., Howell, S. J., Farnie, G., & Clarke, R. B. (2013) · Breast Cancer Research · doi:10.1186/bcr3436 · Cited by 249
The Wnt/β-catenin pathway regulates growth and maintenance of colonospheres
Kanwar, S. S., Yu, Y., Nautiyal, J., Patel, B. B., & Majumdar, A. P. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-212 · Cited by 253
“Recent studies have reported the pivotal role of Wnt/b-catenin signaling pathway in the regulation of epithelial stem cell self renewal [28,29].”
BackgroundIthimakin, S., Day, K. C., Malik, F., Zen, Q., Dawsey, S. J., Bersano-Begey, T. F., Quraishi, A. A., Ignatoski, K. W., Daignault, S., Davis, A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3349 · Cited by 236
Self-citationSingh, S., Srivastava, S. K., Bhardwaj, A., Owen, L. B., & Singh, A. P. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605968 · Cited by 225
“Furthermore, Akt can activate b-catenin by inducing direct phosphorylation or by inactivating GSK-3b (Monick et al, 2001; Fang et al, 2007; Korkaya et al, 2009).”
BackgroundIsolation, identification, and characterization of cancer stem cells: A review
Abbaszadegan, M. R., Bagheri, V., Razavi, M. S., Momtazi, A. A., Sahebkar, A., & Gholamin, M. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25759 · Cited by 225
“This assay was has been fulfilled for relatively few solid tumors as well as completed by sphere-forming in vitro LDAs (Hu & Smyth, 2009; Korkaya et al., 2009; Liu et al., 2006; O'Brien, Kreso, & Jamieson, 2010).”
BackgroundMethodCancer stem cells: In the line of fire
Alison, M. R., Lin, W.-R., Lim, S. M. L., & Nicholson, L. J. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.03.003 · Cited by 225
Integrated morphodynamic signalling of the mammary gland
Gjorevski, N., & Nelson, C. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3168 · Cited by 215
Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway
Liu, P.-P., Liao, J., Tang, Z.-J., Wu, W.-J., Yang, J., Zeng, Z.-L., Hu, Y., Wang, P., Ju, H.-Q., Xu, R.-H., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.131 · Cited by 218
Selective targeting of radiation-resistant tumor-initiating cells
Zhang, M., Atkinson, R. L., & Rosen, J. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910179107 · Cited by 216
“2009 (12) and also demonstrate additional mechanisms by which the inhibition of the Akt/Wnt/β-catenin pathway may be used in conjunction with conventional radiation and chemotherapy to target not only the majority of the tumor cells, but also the subpopulation of TICs.”
BackgroundMethodID1 and ID3 Regulate the Self-Renewal Capacity of Human Colon Cancer-Initiating Cells through p21
O'Brien, C. A., Kreso, A., Ryan, P., Hermans, K. G., Gibson, L., Wang, Y., Tsatsanis, A., Gallinger, S., & Dick, J. E. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.036 · Cited by 222
“However, recently, many groups have commenced utilizing sphere (serum-free media) or colony-forming (10% serum media) assays as attractive surrogates (Todaro et al., 2008; Korkaya et al., 2009).”
BackgroundRetinoid signaling regulates breast cancer stem cell differentiation
Ginestier, C., Wicinski, J., Cervera, N., Monville, F., Finetti, P., Bertucci, F., Wicha, M. S., Birnbaum, D., & Charafe-Jauffret, E. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9761 · Cited by 217
Self-citationSingh, J. K., Farnie, G., Bundred, N. J., Simões, B. M., Shergill, A., Landberg, G., Howell, S. J., & Clarke, R. B. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1063 · Cited by 217
Sahlberg, S. H., Spiegelberg, D., Glimelius, B., Stenerlöw, B., & Nestor, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094621 · Cited by 181
“AKT induces the nuclear translocation bcatenin through the phosphorylation of GSK3b [14,58].”
BackgroundGrover, P. K., Cummins, A. G., Price, T. J., Roberts-Thomson, I. C., & Hardingham, J. E. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu018 · Cited by 214
“In addition, CTCs from patients with primary or MBC were shown to express receptors and activated signalling kinases of the EGFR/ HER2/PI3K/Akt pathway [169], one of the major signalling pathways involved in the regulation of mammary stem/progenitor cells, promoting the proliferation and inhibition of apoptosis [170].”
BackgroundThe role of aldehyde dehydrogenase (ALDH) in cancer drug resistance
Januchowski, R., Wojtowicz, K., & Zabel, M. (2013) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2013.04.005 · Cited by 202
Hanker, A. B., Pfefferle, A. D., Balko, J. M., Kuba, M. G., Young, C. D., Sánchez, V., Sutton, C. R., Cheng, H., Perou, C. M., Zhao, J. J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303204110 · Cited by 203
PTEN Tumor-Suppressor: The Dam of Stemness in Cancer
Luongo, F., Colonna, F., Calapà, F., Vitale, S., Fiori, M. E., & De Maria, R. (2019) · Cancers · doi:10.3390/cancers11081076 · Cited by 189
Targeting cancer stem cells: a new therapy to cure cancer patients.
Hu, Y., & Fu, L. (2012) · Europe PMC (PubMed Central) · Cited by 264
Targeting breast cancer stem cells
McDermott, S. P., & Wicha, M. S. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.06.005 · Cited by 193
“In agreement, activation of Wnt signaling increased human mammosphere formation (Korkaya et al., 2009).”
BackgroundSelf-citationLin, Y., Yang, Y., Li, W., Chen, Q., Li, J., Pan, X., Zhou, L., Liu, C., Chen, C., He, J., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.08.030 · Cited by 190
“Moreover, emerging evidence indicates that the PI3K-Akt signaling pathway plays a key role in CSC biology (Bleau et al., 2009; Dubrovska et al., 2009; Li and Zhou, 2011) and could be an effective drug target for killing CSCs (Eyler et al., 2008; Korkaya et al., 2009; Martelli et al., 2011).”
BackgroundSOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K/AKT/SOX2 axis and beyond
Schaefer, T., & Lengerke, C. (2020) · Oncogene · doi:10.1038/s41388-019-0997-x · Cited by 197
“(cancer) stem cell characteristics on the other: Mutations in PTEN for example support the outgrowth of healthy and malignant mammary epithelium derived stem cells, which can be antagonized by the PI3K/AKT cross-reactive inhibitor perifosine [90].”
BackgroundTargeting cancer stem cells by curcumin and clinical applications
Li, Y., & Zhang, T. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.012 · Cited by 189
Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy
Borah, A., Raveendran, S., Rochani, A., Maekawa, T., & Kumar, D. S. (2015) · Oncogenesis · doi:10.1038/oncsis.2015.35 · Cited by 192
Książkiewicz, M., Markiewicz, A., & Żaczek, A. J. (2012) · Pathobiology · doi:10.1159/000337106 · Cited by 190
Estrogen receptor alpha-36 (ER-α36): A new player in human breast cancer
Wang, Z.-Y., & Yin, L. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.04.017 · Cited by 183
Velasco-Velázquez, M. A., Homsi, N., De La Fuente, M., & Pestell, R. G. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.12.020 · Cited by 185
Breast cancer stem cells: Features, key drivers and treatment options
Dittmer, J. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.07.007 · Cited by 188
Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds
Li, Y., Wicha, M. S., Schwartz, S. J., & Sun, D. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.11.001 · Cited by 179
“are capable of continuous self-renewal and differentiation [15,27] (Fig.”
BackgroundInfluentialSelf-citationSimvastatin induces derepression of PTEN expression via NFκB to inhibit breast cancer cell growth
Ghosh-Choudhury, N., Mandal, C. C., Ghosh-Choudhury, N., & Ghosh Choudhury, G. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2009.12.010 · Cited by 177
Molecular characterization and targeted therapeutic approaches in breast cancer
Toss, A., & Cristofanilli, M. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0560-9 · Cited by 170
“Pharmacological inhibition of Akt may reduce tumor growth and regulate malignant stem cells [47].”
BackgroundBreast-cancer stem cells—beyond semantics
Badve, S., & Nakshatri, H. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70191-7 · Cited by 174
The role of microRNAs in the regulation of cancer stem cells
Takahashi, R.-U., Miyazaki, H., & Ochiya, T. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2013.00295 · Cited by 118
“Korkaya et al. reported that the Wnt/β-catenin pathway is involved in the regulation of normal and malignant mammary stem/progenitor cell populations (Korkaya et al., 2009).”
BackgroundSuman, S., Das, T. P., & Damodaran, C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.642 · Cited by 166
“More importantly, activation of AKT increases mammosphere formation in BCCs (Korkaya et al, 2009).”
BackgroundJang, G.-B., Hong, I.-S., Kim, R.-J., Lee, S.-Y., Park, S.-J., Lee, E.-S., Park, J. H., Yun, C.-H., Chung, J.-U., Lee, K.-J., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2041 · Cited by 163
Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications
Zeng, X., Liu, C., Yao, J., Wan, H., Wan, G., Li, Y., & Chen, N. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105320 · Cited by 164
Zhang, X., Powell, K. A., & Li, L. (2020) · Cancers · doi:10.3390/cancers12123765 · Cited by 176
Cancer stem cells (CSCs), cervical CSCs and targeted therapies
Huang, R., & Rofstad, E. K. (2017) · Oncotarget · doi:10.18632/oncotarget.10169 · Cited by 159
“, PTEN/Akt/ β-catenin signalling and PTEN/Akt/PI3K signalling [176, 177].”
Zhang, Z., Cheng, L., Li, J., Farah, E., Atallah, N. M., Pascuzzi, P. E., Gupta, S., & Liu, X. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3006 · Cited by 157
“Growing evidence shows that Wnt/β-catenin signaling is highly active in CSCs and may have a role in prostate stem cell self-renewal (21,22).”
BackgroundConcise Review: Targeting Cancer Stem Cells Using Immunologic Approaches
Pan, Q., Li, Q., Liu, S., Ning, N., Zhang, X., Xu, Y., Chang, A. E., & Wicha, M. S. (2015) · Stem Cells · doi:10.1002/stem.2039 · Cited by 158
Self-citationCytoplasmic Localization of β-Catenin is a Marker of Poor Outcome in Breast Cancer Patients
López‐Knowles, E., Zardawi, S. J., McNeil, C. M., Millar, E. K. A., Crea, P., Musgrove, E. A., Sutherland, R. L., & O'Toole, S. A. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0741 · Cited by 150
“Recently, an important role for PI3K/AKT/ β catenin pathway has been identified in the regulation of malignant stem/progenitor cell populations, suggesting that inhibiting this pathway could be an effective method to target tumorigenic breast cancer cells (37).”
Malignant Precursor Cells Pre-Exist in Human Breast DCIS and Require Autophagy for Survival
Espina, V. A., Mariani, B. D., Gallagher, R. I., Tran, K., Banks, S., Wiedemann, J., Huryk, H., Mueller, C., Adamo, L., Deng, J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010240 · Cited by 147
“We did not enzymatically dissociate the DCIS lesions and then conduct flow sorting as has been done for studies of breast carcinoma [45–47].”
BackgroundResultKey signaling nodes in mammary gland development and cancer: β-catenin
Incassati, A., Chandramouli, A., Eelkema, R., & Cowin, P. (2010) · Breast Cancer Research · doi:10.1186/bcr2723 · Cited by 147
Chemical Control of Stem Cell Fate and Developmental Potential
Lyssiotis, C. A., Lairson, L. L., Boitano, A. E., Wurdak, H., Zhu, S., & Schultz, P. G. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201004284 · Cited by 156
Prabhu, V. V., Allen, J. E., Dicker, D. T., & El‐Deiry, W. S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-13-3451 · Cited by 142
Overcoming Wnt–β-catenin dependent anticancer therapy resistance in leukaemia stem cells
Perry, J. M., Fang, T., Roy, A., Lin, T. L., He, X., Chen, S., Lü, X., Nemechek, J. M., Ruan, L., Yu, X., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0507-y · Cited by 143
Self-citationOncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells
Guo, S., Liu, M., Wang, G., Torroella‐Kouri, M., & Gonzalez-Perez, R. R. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.01.002 · Cited by 160
Genistein decreases the breast cancer stem-like cell population through Hedgehog pathway
Fan, P., Fan, S., Wang, H., Mao, J., Shi, Y., Ibrahim, M. M., Ma, W., Yu, X., Hou, Z., Wang, B., et al. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt357 · Cited by 145
“There has been compelling evidence that many cancer types, including breast cancer, are initiated from and maintained by a small population of cancer stem cells [7,8].”
BackgroundMetabolic alterations in cancer cells and therapeutic implications
Hammoudi, N., Ahmed, K. B. R., García-Prieto, C., & Huang, P. (2011) · 癌症:英文版 · doi:10.5732/cjc.011.10267 · Cited by 150
miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling
Helou, R. E., Pinna, G., Cabaud, O., Wicinski, J., Bhajun, R., Guyon, L., Rioualen, C., Finetti, P., Gros, A., Mari, B. P., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.016 · Cited by 136
Self-citationFeigin, M. E., Akshinthala, S. D., Araki, K., Rosenberg, A. Z., Muthuswamy, L. B., Martin, B., Lehmann, B. D., Berman, H. K., Pietenpol, J. A., Cardiff, R. D., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3415 · Cited by 135
“Knockdown of PTEN in normal mammary epithelial cells implanted into humanized mouse fat pads resulted in disorganized, hyperplastic lesions (44).”
BackgroundCancer stem cells in breast cancer and metastasis
Lawson, J. C., Blatch, G. L., & Edkins, A. L. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0524-9 · Cited by 146
“The mammary stem cell population is enriched by Wnt pathway signalling events and can be increased by inhibitors of PTEN that lead to activation of the Wnt/beta-catenin pathway [82].”
BackgroundThe Breast Cancer Stem Cells Traits and Drug Resistance
Zheng, Q., Zhang, M., Zhou, F., Zhang, L., & Meng, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.599965 · Cited by 139
Finding cancer stem cells: are aldehyde dehydrogenases fit for purpose?
Alison, M. R., Guppy, N., Lim, S. M. L., & Nicholson, L. J. (2010) · The Journal of Pathology · doi:10.1002/path.2772 · Cited by 147
Mouse models of liver cancer: Progress and recommendations
He, L., Tian, D., Li, P., & He, X. (2015) · Oncotarget · doi:10.18632/oncotarget.4202 · Cited by 147
Breast cancer stem cells: treatment resistance and therapeutic opportunities
Al‐Ejeh, F., Smart, C. E., Morrison, B. J., Chenevix‐Trench, G., López, J. A., Lakhani, S. R., Brown, M. P., & Khanna, K. K. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr028 · Cited by 145
Self-citationD'Angelo, R. C., Ouzounova, M., Davis, A., Choi, D., Tchuenkam, S. M., Kim, G., Luther, T. K., Quraishi, A. A., Şenbabaoğlu, Y., Conley, S. J., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0228 · Cited by 139
“Moreover our previous studies demonstrated that the Wnt/b-catenin pathway is selectively activated in breast CSCs (19).”
BackgroundSelf-citationPI3K/mTOR Dual Inhibitor VS-5584 Preferentially Targets Cancer Stem Cells
Kolev, V. N., Wright, Q. G., Vidal, C. M., Ring, J. E., Shapiro, I. M., Ricono, J. M., Weaver, D. T., Padval, M. V., Pachter, J. A., & Xu, Q. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1223 · Cited by 131
Montales, M. T. E., Rahal, O. M., Kang, J., Rogers, T. J., Prior, R. L., Wu, X., & Simmen, R. C. M. (2012) · Carcinogenesis · doi:10.1093/carcin/bgr317 · Cited by 126
Srivastava, R. K., Tang, S., Zhu, W., Meeker, D., & Shankar, S. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e266 · Cited by 127
Chui, M. H. (2012) · International Journal of Cancer · doi:10.1002/ijc.27745 · Cited by 132
“Furthermore, TGF-b signaling cross-talks with the Wnt pathway,(80) which has been implicated in the regulation of mammary stem/progenitor cells.(81) Therefore, instead of EMT being a novel mechanism to generate cancer stem cells, perhaps a more fitting and parsimonious conclusion may be that Snail, Twist or TGF-b sign…”
BackgroundMetformin: A Potential Therapeutic Agent for Recurrent Colon Cancer
Nangia‐Makker, P., Yu, Y., Vasudevan, A., Farhana, L., Rajendra, S. G., Levi, E., & Majumdar, A. P. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084369 · Cited by 131
“Many investigators have reported the pivotal role of Wnt/bcatenin signaling pathway in the regulation of epithelial stem cell self-renewal [21,22], and its dysregulation has been implicated in many malignancies including colorectal cancer (CRC) [23,24].”
BackgroundDubrovska, A., Elliott, J., Salamone, R. J., Kim, S., Aimone, L. J., Walker, J. R., Watson, J., Maira, S.-M., García-Echeverría, C., Cho, C. Y., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1601 · Cited by 126
HER2 and Breast Cancer Stem Cells: More than Meets the Eye
Körkaya, H., & Wicha, M. S. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0260 · Cited by 120
Self-citationHypoxia in Solid Tumors: How Low Oxygenation Impacts the “Six Rs” of Radiotherapy
Rakotomalala, A., Escande, A., Furlan, A., Meignan, S., & Lartigau, E. F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.742215 · Cited by 127
Metadata
- Authors
- Korkaya, H., Paulson, A., Charafe-Jauffret, E., Ginestier, C., Brown, M., Dutcher, J., Clouthier, S. G., & Wicha, M. S.
- Affiliations
- University of Michigan (US)
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-06-02
- Volume
- 7
- Issue
- 6
- Pages
- e1000121
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC2683567
- OpenAlex
- W2009094422
- Cited by
- 523
- References
- 58
- Citations by year
- 2025: 8 · 2024: 11 · 2023: 16 · 2022: 21 · 2021: 21 · 2020: 23 · 2019: 21 · 2018: 21 · 2017: 23 · 2016: 39 · 2015: 59 · 2014: 42 · 2013: 65 · 2012: 64
- FWCI
- 25.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- University of Michigan
- A. Alfred Taubman Medical Research Institute
- National Institutes of Health (CA46592)
- School of Medicine, Stanford University
- National Cancer Institute (CA101860, 5P30 CA 46592, R01CA129765, CA129765, R01CA101860, P30CA046592)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Keywords
- mammary stem/progenitor cells, PTEN, Akt signaling, Wnt/β-catenin signaling, breast cancer, perifosine, PI3K/Akt signaling, atypical hyperplasia, breast tumor xenografts, cancer stem cells
- MeSH terms
- Animals, Breast, Breast Neoplasms, Female, Gene Expression Regulation, Humans, Mammary Glands, Animal, Stem Cells, Neoplastic Stem Cells, Signal Transduction, Mice, SCID, Mice, Inbred NOD, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, PTEN Phosphohydrolase, beta Catenin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.